<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">mvjr</journal-id><journal-title-group><journal-title xml:lang="en">Medical Herald of the South of Russia</journal-title><trans-title-group xml:lang="ru"><trans-title>Медицинский вестник Юга России</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2219-8075</issn><issn pub-type="epub">2618-7876</issn><publisher><publisher-name>The Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2219-8075-2022-13-4-100-105</article-id><article-id custom-type="elpub" pub-id-type="custom">mvjr-1602</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PAEDIATRICS</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПЕДИАТРИЯ</subject></subj-group></article-categories><title-group><article-title>Skin microbiota of children with acute urticaria of varying severity</article-title><trans-title-group xml:lang="ru"><trans-title>Микробиота кожи детей с острой крапивницей различной степени тяжести</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0937-4573</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Набока</surname><given-names>Ю. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Naboka</surname><given-names>Y. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Набока Юлия Лазаревна - доктор медицинских наук, профессор, заведующая кафедрой микробиологии и вирусологии №1.</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Yulia L. Naboka - Dr. Sci. (Med.), Professor, head of Department of microbiology and virology №1, Rostov State Medical University.</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">nagu22@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лебеденко</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Lebedenko</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лебеденко Александр Анатольевич – доктор медицинских наук, профессор, заведующий кафедрой детских болезней №2.</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Alexander A. Lebedenko - Dr. Sci. (Med.), Professor, head of the Department of children's diseases №2, Rostov State Medical University.</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">leb.rost@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Посевина</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Posevina</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Посевина Анастасия Николаевна – кандидат медицинских наук, ассистент кафедры детских болезней №2.</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Anastasia N. Posevina - Cand. Sci. (Med.), аssistant of the Department of сhildren's diseases №2, Rostov State Medical University.</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">anastasia240890@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аверкина</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Averkina</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Аверкина Лидия Александровна - ассистент кафедры детских болезней №2.</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Lydia А. Averkina - аssistant of the Department of сhildren's diseases №2, Rostov State Medical University.</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">averkina.lidija@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванникова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivannikova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Иванникова Евгения Валерьевна - кандидат медицинских наук, ассистент кафедры микробиологии и вирусологии №1.</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Eugenia V. Ivannikova - Cand. Sci. (Med.), assistant of Department of microbiology and virology №1, Rostov State Medical University.</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">mitus21@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1360-8608</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кудря</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kudrya</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кудря Елена Васильевна - ассистент кафедры микробиологии и вирусологии №1.</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Elena V. Kudrya - assistant of Department of microbiology and virology N1.</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">kudryadom@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ростовский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>01</day><month>01</month><year>2023</year></pub-date><volume>13</volume><issue>4</issue><fpage>100</fpage><lpage>105</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Naboka Y.L., Lebedenko A.A., Posevina A.N., Averkina L.A., Ivannikova E.V., Kudrya E.V., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Набока Ю.Л., Лебеденко А.А., Посевина А.Н., Аверкина Л.А., Иванникова Е.В., Кудря Е.В.</copyright-holder><copyright-holder xml:lang="en">Naboka Y.L., Lebedenko A.A., Posevina A.N., Averkina L.A., Ivannikova E.V., Kudrya E.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medicalherald.ru/jour/article/view/1602">https://www.medicalherald.ru/jour/article/view/1602</self-uri><abstract><p>Objective: to evaluate changes in the skin microbiota of the children with acute urticaria of varying severity. Materials and methods: a total of 94 children aged 3 to 14 years old were examined. Four clinical groups were formed. Group I (n=15) included children with mild acute urticaria, group II (n=32) – with moderate course, group III (n=16) – with severe form, and group IV (n=31) – children of the 1 and 2a health group (control group). All patients underwent a comprehensive clinical and laboratory examination, as well as a qualitative and quantitative assessment of the skin microbiota. The sampling of the material for bacteriological examination was carried out from the area of the middle third of the forearm on the affected area of the skin and on a symmetrical unaffected area in patients with acute urticaria. In the control group, the material was taken from the corresponding area of the forearm skin. Results: in the unaffected area of the skin in patients of group I, the rate of detection of Propionibacterium spp. (p&lt;0.05) was increased, in group II, the rate of detection of Bacteroides spp. was increased (p&lt;0.05), and in group III, the rate of detection of S. aigeis was increased and Micrococcus spp. (p&lt;0.05) was reduced in comparison with the microbiota indicators of children in group IV. On the affected area of the skin in children of group II, the detection rate of Bacteroides spp. was significantly increased (p&lt;0.05) and the detection rate of Bacillus spp. (p&lt;0.05) was decreased, in children of group IV, the studied feature was increased for S. aureus (p&lt;0.05). Conclusions: the data obtained during the study indicate differences in microbial patterns of the skin depending on the severity of the course of acute urticaria in children.</p></abstract><trans-abstract xml:lang="ru"><p>Цель: оценить изменения микробиоты кожи у детей с острой крапивницей различной степени тяжести. Материалы и методы: обследовано 94 ребенка в возрасте от 3 до 14 лет. Сформированы четыре клинические группы: I группа (n=15) — дети с лёгким течением острой крапивницы, II группа (n=32) — со среднетяжёлым течением, III группа (n=16) — с тяжёлой формой, IV группа (n=31) — дети 1 и 2а групп здоровья (контрольная группа). Всем пациентам выполнено комплексное клинико-лабораторное обследование, а также произведена качественная и количественная оценка микробиоты кожи. Забор материала для бактериологического исследования проводился с области средней трети предплечья на поражённом участке кожи и на симметричном непоражённом участке у пациентов с острой крапивницей. В контрольной группе забор материала производили с соответствующего участка кожи предплечья. Результаты: на непоражённом участке кожи у больных I группы повышена частота обнаружения Propionibacterium sрp. (р&lt;0,05), во II группе — Bacteroides sрp. (р&lt;0,05), а в III группе повышена частота обнаружения S. аureus и снижена частота обнаружения Micrococcus sрp. (р&lt;0,05) в сравнении с показателями микробиоты детей IV группы. На поражённом участке кожи у детей II группы достоверно повышена (р&lt;0,05) частота обнаружения Bacteroides sрp. и снижена частота обнаружения Bacillus spp. (р&lt;0,05), а у детей IV группы исследуемый признак повышен для S.aureus (р&lt;0,05). Выводы: полученные в ходе проведённого исследования данные свидетельствуют о различиях микробных паттернов кожи в зависимости от тяжести течения острой крапивницы у детей.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>микробиота кожи</kwd><kwd>острая крапивница</kwd><kwd>дети</kwd><kwd>атопия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>skin microbiota</kwd><kwd>acute urticaria</kwd><kwd>children</kwd><kwd>atopia</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>Acute urticaria (AU) is one of the current and significant problems in modern pediatrics. According to the results of epidemiological studies, the prevalence of urticaria in the pediatric population reaches 6.7% [<xref ref-type="bibr" rid="cit1">1</xref>][<xref ref-type="bibr" rid="cit2">2</xref>]. The development of this urgent condition is associated with a variety of etiological factors, which often complicates the diagnostic search for a leading trigger and therapeutic tactics [<xref ref-type="bibr" rid="cit3">3</xref>][<xref ref-type="bibr" rid="cit4">4</xref>].</p><p>Currently, a special role is attributed to the microbiota and/or skin microbiome in the development of various allergic dermatoses [<xref ref-type="bibr" rid="cit5">5</xref>][<xref ref-type="bibr" rid="cit6">6</xref>]. In particular, a correlation between the diversity of the skin microbiome and the severity of the course of atopic dermatitis was established [<xref ref-type="bibr" rid="cit7">7</xref>]. A correlation was revealed between an increase in the count of S. aureus on the skin and an increase in serum IgE concentration. S. aureus has a powerful arsenal of pathogenicity factors that often act as triggers of allergic reactions [<xref ref-type="bibr" rid="cit8">8</xref>]. At the same time, the role of changes in the skin microbiota in the genesis and the influence on the severity of the course of AU remains understudied.</p><p>The study aimed to evaluate changes in the skin microbiota of children with AU of varying severity.</p></sec><sec><title>Materials and Methods</title><p>A clinical and laboratory examination was performed in 94 children aged 3 to 12 years old (mean age – 8.3±3.2 years). The subjects were divided into four groups. The first three groups were children diagnosed with AU of varying severity: Group I (n=15) – mild course of the disease, Group II (n=32) – moderate course, and Group III (n=16) – a severe form of AU. Group IV (n=31), the control group, included children of health groups 1 and 2a. The inclusion criteria for Groups I, II, and III were age 3–12 years old, diagnosis of AU, absence of concomitant dermatological diseases, and informed parental consent. Group IV inclusion criteria were age 3–12 years old, health groups 1 and 2a, and informed parental consent. In children with AU, the skin microbiota of two areas (the affected and symmetrical unaffected) of the middle third of the inner surface of the forearm was examined. In the control group, material was collected from the surface of the topically corresponding locus. Bacteriological skin examination was performed according to the method of Pokatilov (1993). The smear-prints were taken according to methodical guidelines MU 4.2.2 039-05 (2006), recommendations by Menshikov (2009) and Murray (2015), using a bacterial stamp sampler with different nutrient media [<xref ref-type="bibr" rid="cit9">9</xref>][<xref ref-type="bibr" rid="cit10">10</xref>]. The authors used an extended set of nutrient media for aerobic and anaerobic microbiota taxa in aerobic and anaerobic cultivation conditions, respectively. AnaeroHiGas PaK was used to create the latter. Identification of microorganisms verified in the studied loci was performed according to generally accepted methods.</p><p>Statistical analysis was performed in the software R (version 3.2, R Foundation for Statistical Computing, Vienna, Austria). The differences were analyzed based on the occurrence rate and concentration estimates. In the analysis of quantitative characteristics of different microbiota taxa verified on the skin, mean values were calculated as median (Me), lower quartile (LQ), and upper quartile (VQ). Ward’s method (Bray–Curtis dissimilarity) was used for similarity analysis. The Mann-Whitney test and Fisher’s exact test were also used to compare unrelated groups.</p></sec><sec><title>Results</title><p>A comparative analysis of the microbiota in the unaffected skin area in the studied groups of patients with AU and the control group revealed significant differences in 8 microbial taxa (Table 1). Group I patients showed an increase in the detection rate of Propionibacterium spp. (p=0.04), and in Group II – Bacteroides spp. (p=0.001). In patients with severe AU (Group III), there was an increase in the studied index for S. aureus (p=0.003) and a decrease in Micrococcus spp. (0.001). In Group IV, there was an increase in the detection rate of S. epidermidis (p=0.006) and Bacillus spp.</p><table-wrap id="table-1"><caption><p>Table 1</p><p>Significant differences in the detection rates (%) of single representatives of the skin microbiota (unaffected skin area) in children from the studied groups</p><p>Note: The comparison was carried out using an accurate Fischer test. *p&lt;0.05</p></caption><table><tbody><tr><td>S.aureus</td><td>73.3</td><td>56.2</td><td>93.7</td><td>38.7</td><td>0.003*</td></tr><tr><td>S.epidermidis</td><td>53.3</td><td>68.7</td><td>50.0</td><td>90.3</td><td>0.006*</td></tr><tr><td>S.haemolyticus</td><td>0</td><td>0</td><td>0</td><td>16.1</td><td>0.009*</td></tr><tr><td>Micrococcus spр.</td><td>20.0</td><td>25.0</td><td>12.5</td><td>61.3</td><td>0.001*</td></tr><tr><td>Bacillus spp.</td><td>20.0</td><td>3.1</td><td>6.2</td><td>35.5</td><td>0.006*</td></tr><tr><td>Enterococcus spp.</td><td>0</td><td>0</td><td>0</td><td>16.1</td><td>0.007*</td></tr><tr><td>Non-clostridial anaerobic bacteria</td></tr><tr><td>Propionibacterium sрp.</td><td>53.3</td><td>40.6</td><td>25.0</td><td>16.1</td><td>0.04*</td></tr><tr><td>Bacteroides sрp.</td><td>13.3</td><td>31.2</td><td>6.2</td><td>0</td><td>0.001*</td></tr></tbody></table></table-wrap><p>A comparison of the microbiota in the affected skin area of patients with AU of different severity and children from the control group (Table 2) revealed several differences in the occurrence rate of bacteria. In Group II, the detection rate of Bacteroides spp. (p=0.0005) increased and Bacillus spp. –decreased (p=0.009). In Group II, the studied indicator for S. aureus was elevated (p=0.02). At the same time, in the control group, the detection rate of S. epidermidis was significantly increased (p=0.009) and there were no Bacteroides spp. detected.</p><table-wrap id="table-2"><caption><p>Table 2</p><p>Significant differences in the detection rates (%) of single representatives of the skin microbiota (affected skin area) in children from the studied groups</p><p>Note: The comparison was carried out using an accurate Fischer test. *p&lt;0.05</p></caption><table><tbody><tr><td>Bacteroides sрp.</td><td>26.67</td><td>40.62</td><td>12.50</td><td>0</td><td>0.0005*</td></tr></tbody></table></table-wrap><p>It should be noted that there was a significant increase in the detection rate of S. aureus in children with severe AU in both studied skin loci.</p><p>A comparative analysis of the mean concentrations of microorganisms verified on the unaffected skin area in patients with AU and the control group revealed significant differences in some microbial taxa (Table 3). In Group I, there was an increase in the studied index for S. epidermidis and a decrease for Peptococcus spp., Peptostreptococcus spp., and Veillonella spp. Group II showed a decrease in the concentration of Propionibacterium spp. In Group III, an increase in the concentration of Peptococcus spp. was registered. At the same time, in the control group, an increase in the concentration of Peptostreptococcus spp. and Propionibacterium spp. and a decrease in S. epidermidis were recorded compared to patients with AU of different severity.</p><table-wrap id="table-3"><caption><p>Table 3</p><p>Comparative analysis of the levels of the skin microbiota representatives (unaffected skin area) in children from the studied groups</p><p>Note: the data in the table are presented in the form of Me [LQ, VQ]; the comparison was carried out using the Kruskal-Wallis test. For cases when the indicator was not determined for all the observed in the group, the cell is left empty. *p&lt;0.05</p></caption><table><tbody><tr><td>Peptococcus sрp.</td><td>1.0 [ 1.0; 3.3]</td><td>1.0 [ 0.5; 2.0]</td><td>2.0 [ 1.3; 5.0]</td><td>2.5 [ 1.75; 3.0]</td><td>0.007*</td></tr><tr><td>Peptostreptococcus sрp.</td><td>1.0 [ 0.25; 1.0]</td><td>1.15 [ 1.0; 2.0]</td><td>1.3 [ 0.5; 2.0]</td><td>3.0 [ 1.0; 3.0]</td><td>0.02*</td></tr><tr><td>Propionibacterium sрp.</td><td>0.75 [ 0.3; 1]</td><td>0.3 [ 0.3; 0.3]</td><td>0.62 [ 0.4; 0.88]</td><td>1.25 [ 1.0; 1.25]</td><td>0.001*</td></tr><tr><td>Veillonella spp.</td><td>1.0 [ 1.0;1.0]</td><td>1.0 [ 1.0; 1.0]</td><td>1.0 [ 1.0; 1.0]</td><td>3.0 [ 3.0; 3.2]</td><td>0.007*</td></tr><tr><td>Bacteroides sрp.</td><td>0.75 [ 0.5; 1.0]</td><td>0.5 [ 0.5; 0.5]</td><td>0.3 [ 0.3; 0.3]</td><td> </td><td>0.2</td></tr><tr><td>Eubacterium sрp.</td><td> </td><td> </td><td> </td><td>1.0 [ 0.75; 1.2]</td><td> </td></tr></tbody></table></table-wrap><p>A similar analysis of the affected skin area of patients with AU compared to that of control children revealed significant differences in only 1 taxon (Veillonella spp.) (Table 4). Thus, regardless of the severity of the studied pathology, the median value of Veillonella spp. concentration was 100.3 CFU/cm², and in Group IV, this value was 103 CFU/cm².
</p><table-wrap id="table-4"><caption><p>Table 4</p><p>Comparative analysis of the levels of the skin microbiota representatives (affected skin area) in children from the studied groups</p><p>Note: the data in the table are presented in the form of Me [LQ, VQ]; the comparison was carried out using the Kruskal-Wallis test. For cases when the indicator was not determined for all the observed in the group, the cell is left empty. *p&lt;0.05</p></caption><table><tbody><tr><td>Microorganisms</td><td>Groups</td><td> </td><td>P</td></tr><tr><td>I</td><td>II</td><td>III</td><td>IV</td></tr><tr><td>S. aureus</td><td>1.5 [ 1.25; 2]</td><td>1.25 [ 0.62; 4.5]</td><td>1.75 [ 1.25; 2.5]</td><td>5.0 [ 1.38; 12.2]</td><td>0.3</td></tr><tr><td>S. epidermidis</td><td>1.75 [ 1; 2.5]</td><td>1.25 [ 0.3; 1.6]</td><td>2.0 [ 1.02; 6]</td><td>1.12 [ 0.8; 2.0]</td><td>0.1</td></tr><tr><td>S. haemolyticus</td><td> </td><td> </td><td> </td><td>0.6 [ 0.5; 0.75]</td><td> </td></tr><tr><td>Micrococcus sрp.</td><td>1.75 [ 0.8; 2.0]</td><td>0.8 [ 0.75; 2.0]</td><td>0.8 [ 0.75; 2.0]</td><td>1.3 [ 1.0; 3.25]</td><td>0.3</td></tr><tr><td>Corynebacterium sрp.</td><td>4.85 [ 1.0; 12.5]</td><td>4.35 [ 1.7; 5.25]</td><td>6.38 [ 3.7; 8.0]</td><td>2.75 [ 0.25; 2.75]</td><td>0.1</td></tr><tr><td>Bacillus spp.</td><td>1.38 [ 1.0; 1.75]</td><td>1.75 [ 1.75; 1.75]</td><td>1.12 [ 0.75; 1.5]</td><td>0.75 [ 0.5; 1.5]</td><td>0.1</td></tr><tr><td>Enterococcus spp.</td><td> </td><td> </td><td> </td><td>3.0 [ 2.8; 3.0]</td><td> </td></tr><tr><td>Peptococcus sрp.</td><td>2.0 [ 1.0; 3.0]</td><td>1.0 [ 0.3; 2.5]</td><td>0.5 [ 0.3; 3]</td><td>2.5 [ 1.75; 3.0]</td><td>0.1</td></tr><tr><td>Peptostreptococcus sрp.</td><td>3.0 [ 2.0; 3.0]</td><td>2.5 [ 1.0; 3.5]</td><td>3.0 [ 1.0; 4.2]</td><td>3.0 [ 1.0; 3.0]</td><td>1</td></tr><tr><td>Propionibacterium sрp.</td><td>2.0 [ 0.65; 3.0]</td><td>0.5 [ 0.5; 0.5]</td><td>0.75 [ 0.5; 2.0]</td><td>1.25 [ 1.0; 1.25]</td><td>0.3</td></tr><tr><td>Veillonella spp.</td><td>0.3 [ 0.3; 0.3]</td><td>0.3 [ 0.3; 0.3]</td><td> </td><td>3.0 [ 3.0; 3.2]</td><td>0.01*</td></tr><tr><td>Bacteroides sрp.</td><td>2.0 [ 0.65; 3.0]</td><td>0.5 [ 0.3; 0.5]</td><td>2.0 [ 1.0; 3.0]</td><td> </td><td>0.1</td></tr><tr><td>Fusobacterium sрp.</td><td> </td><td>0.75 [ 0.75; 0.75]</td><td>0.45 [ 0.4; 0.5]</td><td> </td><td>0.7</td></tr><tr><td>Eubacterium sрp.</td><td>3.0 [ 3.0; 3.0]</td><td>2.5 [ 2.5; 2.5]</td><td>0.5 [ 0.3; 2.75]</td><td>1.0 [ 0.75; 1.2]</td><td>0.4</td></tr></tbody></table></table-wrap></sec><sec><title>Discussion</title><p>Skin microbiota and its species composition directly affect the course of various skin diseases and AU is not an exception [<xref ref-type="bibr" rid="cit11">11</xref>]. Quantitative and qualitative changes in the skin microbiota are associated with the severity of the course of atopic dermatitis [<xref ref-type="bibr" rid="cit12">12</xref>]. S. aureus often acts as a direct microbial marker of such conditions [<xref ref-type="bibr" rid="cit13">13</xref>]. Clausen et al. in their works draw attention to the fact that the increase in skin colonization by S. aureus contributes to a decrease in filaggrin levels. It leads to increased skin pH and skin barrier impairments, thereby, aggravating the course of atopic dermatitis [<xref ref-type="bibr" rid="cit14">14</xref>][<xref ref-type="bibr" rid="cit15">15</xref>]. S. aureus can exacerbate the course of atopy by expressing virulence factors, causing skin barrier disruption and inflammatory changes [<xref ref-type="bibr" rid="cit7">7</xref>].</p><p>The present study of microbiota in the affected and unaffected skin areas in patients with urticaria proves the influence of dysbiotic changes in the skin microbiocenosis on the course and prognosis of the disease. The obtained data on the increased detection rate of S. aureus on the skin of children with AU of various severity compared to healthy children are consistent with the results of studies on the skin microbiota in other atopic diseases [<xref ref-type="bibr" rid="cit13">13</xref>]. According to the present study, the detection rate of S. aureus tends to increase with the aggravation of the course of AU. Thus, the obtained results suggested the influence of Staphylococcus aureus on the development of the severity of the course of urticaria.</p><p>Changes in the composition of the bacterial communities of the skin microbiota may be an important inducer of clinical manifestations in patients with established atopic dermatitis and contribute to the development of exacerbations [<xref ref-type="bibr" rid="cit13">13</xref>]. Drawing an analogy between the results of the available studies [<xref ref-type="bibr" rid="cit5">5</xref>][<xref ref-type="bibr" rid="cit8">8</xref>] and the data obtained in the present study, it can be concluded that the identified changes in the skin microbiota may act as a trigger factor for the development of AU and influence the severity of the disease.</p><p>To date, research is underway to optimize the therapy for atopic dermatitis through microbiota transplantation. Thus, the obtained data can serve as a basis for studying the transplantation of certain types of microorganisms in severe recurrent forms of urticaria in children.</p></sec><sec><title>Conclusions</title><p>Authors’ contribution:</p><p>Naboka Y.L., Lebedenko A.A. – development of research design, text editing and approval of the final version of the manuscript.</p><p>Posevina A.N. – search for literary sources, obtaining and analyzing data, writing the text of the manuscript.</p><p>Averkina L.A., Ivannikova E.V. – search for references, data acquisition and analysis.</p><p>Financing. The study did not have sponsorship.</p><p>Conflict of interest. The authors declare no conflict of interest.</p></sec></body><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Federal clinical guidelines for the care of children with urticaria. Moscow: Union of pediatricians of Russia; 2015. (In Russ).</mixed-citation><mixed-citation xml:lang="en">Federal clinical guidelines for the care of children with urticaria. Moscow: Union of pediatricians of Russia; 2015. (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Pampura A.N., Zakharova I.N., Varlamov E.E., Simakova M.A. Acute urticaria: differential diagnosis and treatment. Meditsinskiy sovet = Medical Council. 2021;(1):187-192. (In Russ.) https://doi.org/10.21518/2079-701X-2021-1-187-192</mixed-citation><mixed-citation xml:lang="en">Pampura A.N., Zakharova I.N., Varlamov E.E., Simakova M.A. Acute urticaria: differential diagnosis and treatment. Meditsinskiy sovet = Medical Council. 2021;(1):187-192. (In Russ.) https://doi.org/10.21518/2079-701X-2021-1-187-192</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bardenikova S.I., Snitko S.Yu., Dovgun O.B., Lobanova E.A., Drozdova N.I. Provoking factors influence on the course of acute allergic reactions (urticaria and angioedema) in children. RMJ. 2019;1(II):71–76. eLIBRARY ID: 38165322</mixed-citation><mixed-citation xml:lang="en">Bardenikova S.I., Snitko S.Yu., Dovgun O.B., Lobanova E.A., Drozdova N.I. Provoking factors influence on the course of acute allergic reactions (urticaria and angioedema) in children. RMJ. 2019;1(II):71–76. eLIBRARY ID: 38165322</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lebedenko A.A., Yalovega G.E., Maltcev S.V., Averkina L.A., Posevina A.N., et al. Dismicroelementoses in children with urticaria of various degrees of severity. Medical Bulletin of the North Caucasus. 2017;12(1):24-27. (In Russ.) https://doi.org/10.14300/mnnc.2017.12007</mixed-citation><mixed-citation xml:lang="en">Lebedenko A.A., Yalovega G.E., Maltcev S.V., Averkina L.A., Posevina A.N., et al. Dismicroelementoses in children with urticaria of various degrees of severity. Medical Bulletin of the North Caucasus. 2017;12(1):24-27. (In Russ.) https://doi.org/10.14300/mnnc.2017.12007</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Paller AS, Kong HH, Seed P, Naik S, Scharschmidt TC, et al. The microbiome in patients with atopic dermatitis. J Allergy Clin Immunol. 2019;143(1):26-35. Erratum in: J Allergy Clin Immunol. 2019;143(4):1660. https://doi.org/10.1016/j.jaci.2018.11.015</mixed-citation><mixed-citation xml:lang="en">Paller AS, Kong HH, Seed P, Naik S, Scharschmidt TC, et al. The microbiome in patients with atopic dermatitis. J Allergy Clin Immunol. 2019;143(1):26-35. Erratum in: J Allergy Clin Immunol. 2019;143(4):1660. https://doi.org/10.1016/j.jaci.2018.11.015</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Posevina A.N., Lebedenko A.A., Naboka Y.L., Averkina L.A., Zarutsky S.A. Microbiota of the skin of children with acute urticaria. Bulletin of the National Medical and Surgical Center named after N. I. Pirogov. 2016;11(4):56-58. (In Russ.). eLIBRARY ID: 28318013</mixed-citation><mixed-citation xml:lang="en">Posevina A.N., Lebedenko A.A., Naboka Y.L., Averkina L.A., Zarutsky S.A. Microbiota of the skin of children with acute urticaria. Bulletin of the National Medical and Surgical Center named after N. I. Pirogov. 2016;11(4):56-58. (In Russ.). eLIBRARY ID: 28318013</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hülpüsch C, Tremmel K, Hammel G, Bhattacharyya M, de Tomassi A, et al. Skin pH-dependent Staphylococcus aureus abundance as predictor for increasing atopic dermatitis severity. Allergy. 2020;75(11):2888-2898. https://doi.org/10.1111/all.14461</mixed-citation><mixed-citation xml:lang="en">Hülpüsch C, Tremmel K, Hammel G, Bhattacharyya M, de Tomassi A, et al. Skin pH-dependent Staphylococcus aureus abundance as predictor for increasing atopic dermatitis severity. Allergy. 2020;75(11):2888-2898. https://doi.org/10.1111/all.14461</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Hrestak D, Matijašić M, Čipčić Paljetak H, Ledić Drvar D, Ljubojević Hadžavdić S, Perić M. Skin Microbiota in Atopic Dermatitis. Int J Mol Sci. 2022;23(7):3503. https://doi.org/10.3390/ijms23073503</mixed-citation><mixed-citation xml:lang="en">Hrestak D, Matijašić M, Čipčić Paljetak H, Ledić Drvar D, Ljubojević Hadžavdić S, Perić M. Skin Microbiota in Atopic Dermatitis. Int J Mol Sci. 2022;23(7):3503. https://doi.org/10.3390/ijms23073503</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Menshikov V.V. Methods of clinical and laboratory research. Moscow: Labora; 2009.</mixed-citation><mixed-citation xml:lang="en">Menshikov V.V. Methods of clinical and laboratory research. Moscow: Labora; 2009.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Murray P.R., Rosental K.S., Pfaller M.A. Medical Microbiology. 8-th ed. Philadelphia: Elsevier; 2015.</mixed-citation><mixed-citation xml:lang="en">Murray P.R., Rosental K.S., Pfaller M.A. Medical Microbiology. 8-th ed. Philadelphia: Elsevier; 2015.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lunjani N, Hlela C, O'Mahony L. Microbiome and skin biology. Curr Opin Allergy Clin Immunol. 2019;19(4):328-333. https://doi.org/10.1097/ACI.0000000000000542</mixed-citation><mixed-citation xml:lang="en">Lunjani N, Hlela C, O'Mahony L. Microbiome and skin biology. Curr Opin Allergy Clin Immunol. 2019;19(4):328-333. https://doi.org/10.1097/ACI.0000000000000542</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Capone K, Kirchner F, Klein SL, Tierney NK. Effects of Colloidal Oatmeal Topical Atopic Dermatitis Cream on Skin Microbiome and Skin Barrier Properties. J Drugs Dermatol. 2020;19(5):524-531. PMID: 32484623.</mixed-citation><mixed-citation xml:lang="en">Capone K, Kirchner F, Klein SL, Tierney NK. Effects of Colloidal Oatmeal Topical Atopic Dermatitis Cream on Skin Microbiome and Skin Barrier Properties. J Drugs Dermatol. 2020;19(5):524-531. PMID: 32484623.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Edslev SM, Agner T, Andersen PS. Skin Microbiome in Atopic Dermatitis. Acta Derm Venereol. 2020;100(12):adv00164. https://doi.org/10.2340/00015555-3514</mixed-citation><mixed-citation xml:lang="en">Edslev SM, Agner T, Andersen PS. Skin Microbiome in Atopic Dermatitis. Acta Derm Venereol. 2020;100(12):adv00164. https://doi.org/10.2340/00015555-3514</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Clausen ML, Edslev SM, Andersen PS, Clemmensen K, Krogfelt KA, Agner T. Staphylococcus aureus colonization in atopic eczema and its association with filaggrin gene mutations. Br J Dermatol. 2017;177(5):1394-1400. https://doi.org/10.1111/bjd.15470</mixed-citation><mixed-citation xml:lang="en">Clausen ML, Edslev SM, Andersen PS, Clemmensen K, Krogfelt KA, Agner T. Staphylococcus aureus colonization in atopic eczema and its association with filaggrin gene mutations. Br J Dermatol. 2017;177(5):1394-1400. https://doi.org/10.1111/bjd.15470</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Clausen ML, Agner T, Lilje B, Edslev SM, Johannesen TB, Andersen PS. Association of Disease Severity With Skin Microbiome and Filaggrin Gene Mutations in Adult Atopic Dermatitis. JAMA Dermatol. 2018;154(3):293-300. https://doi.org/10.1001/jamadermatol.2017.5440</mixed-citation><mixed-citation xml:lang="en">Clausen ML, Agner T, Lilje B, Edslev SM, Johannesen TB, Andersen PS. Association of Disease Severity With Skin Microbiome and Filaggrin Gene Mutations in Adult Atopic Dermatitis. JAMA Dermatol. 2018;154(3):293-300. https://doi.org/10.1001/jamadermatol.2017.5440</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
